A recent insurance study links increased car crash claims to legalized recreational marijuana. The Highway Loss Data Institute, a leading insurance research group, said in study results released June 22 that collision claims in Colorado, Washington, and Oregon went up 2.7 percent in the years since legal recreational marijuana sales began when compared with surrounding […]

A new research study in Vancouver is looking for 1,000 dispensary clients to participate in an online survey to help inform the government ahead of legalization. The B.C. Centre on Substance Use (BCCSU) is examining the benefits and potential harms of dispensaries, ahead of the July 2018 legalization deadline set out by the feds. “We […]

Last month a high school senior in Ohio drove off the road on the way home from prom, striking two utility poles and killing his passenger, 17-year-old Lindsey Rotuno. The Ohio Highway Patrol eventually confirmed that driver Chase Johnson, 18, had marijuana in his system. Rotuno was not wearing a seatbelt. Police are still investigating […]

Cannabis could be even better at treating migraines than traditionally recommended medications, a new study has found. Researchers from the Interuniversity Center in Florence, Italy found that pills containing both THC and CBD reduced migraine pain by 43.5 percent. Administration of the drug also led to numerous other benefits, including curbing stomach-aches and muscle pain. […]

Ottawa, ON – ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) announced that it has amended and extended the research contract currently in place between its Canadian operating subsidiary, ABcann Medicinals Inc., and the University of Guelph, of Guelph, Ontario. The agreement, which dates back to Jan. 1, 2015, has been extended to Dec. 31, […]

A new research study in Vancouver is looking for 1,000 dispensary clients to participate in an online survey to help inform the government ahead of legalization. The B.C. Centre on Substance Use (BCCSU) is examining the benefits and potential harms of dispensaries, ahead of the July 2018 legalization deadline set out by the feds. “We […]

The article states: “The companies are targeting more than 100 million Americans who suffer from chronic pain, and are dependent on opioid painkillers such as Vicodin, or addicted to street opiates including heroin.”  “We are grateful that Reuters is covering companies like AXIM that are developing alternatives for the roughly 2.5 million Americans addicted to […]